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Abstract 
Binge eating is a form of disordered eating involving excessive caloric intake in a brief period of 
time, typically from palatable, calorie-dense foods. The underlying neural mechanisms 
controlling this behavior are poorly understood, but likely involve both homeostatic and hedonic 
feeding circuitry. The lateral hypothalamus contains orexin and melanin-concentrating hormone 
(MCH) neurons, both of which are orexigenic neurons that also play roles in stress, reward and 
motivation. It is possible that activation of these neurons is responsible for the development or 
maintenance of binge eating behavior. To test this, we established an animal model of binge 
eating by providing rats with three schedules of intermittent access to a palatable, high fat diet 
(HFD): 6 daily exposures (1wDaily), 6 exposures over 2 weeks on Mondays, Wednesdays and 
Fridays (2wMWF), and 18 exposures over 6 weeks (6wMWF). Rats eagerly consumed the diets 
upon presentation following repeated exposures, consuming up to a quarter of their daily calories 
in a one-hour food exposure, indicative of binge-like behavior. Following 1wDaily or 2wMWF 
feeding, there was no apparent effect of HFD on orexin neurons, but after 6wMWF feeding, 
orexin neurons were significantly hyperpolarized in the HFD group compared to those in 
controls. However, we did not observe any changes in MCH neurons. This suggests that long-
term, but not short-term intermittent access to a palatable diet high in fat induces changes in 
orexin neurons. In conclusion, our results suggest that orexin neurons are unexpectedly inhibited 
by prolonged exposure to feeding patterns that induce binge eating. This may be a homeostatic 
response to repeated binge eating. 
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Chapter 1 - Introduction 
1.1 Binge eating  
 Binge eating refers to episodes of disordered food intake which meet two particular 
criteria: the first refers to feeding in which an excess of calories are consumed in a much smaller 
period of time than would be expected for the size of the meal, and the second affectively 
qualifies the feeding behaviors as accompanied by a feeling of loss of control during the eating. 
The behavior often occurs when individuals are not hungry or in metabolic need for food intake 
and when individuals are alone due to embarrassment over the amount of food consumed, and it 
is accompanied by feelings of shame and guilt (American Psychiatric Association, 2013; Hudson 
et al., 2007; Kessler et al., 2013). The Diagnostic and Statistical Manual of Mental Disorders (5
th
 
ed.; DSM-5; 2013) lists binge eating as a criterion for eating disorders including bulimia nervosa 
(BN), binge eating disorder (BED) as well as eating disorder not otherwise specified, and the 
presence of the behavior is a risk factor for comorbid mental illnesses as well as multiple forms 
of physical health problems (Hudson et al., 2007; Javaras et al., 2008). 
 Binge eating can lead to an increased risk of overweight and obesity, with the number of 
binge eating episodes per month positively correlated with body mass index, and thus carries 
similar increased risks to physical health (Striegel-Moore et al., 2009). Those suffering from BN 
and BED are more likely to suffer from type-II diabetes, and thus are susceptible to further 
deleterious health effects due to the disease (Raevuori et al., 2014). Compared to women without 
BN or BED, women with these eating disorders also reported significantly higher incidence of 
poor or very poor health, as well as reporting higher incidence of specific physical ailments 
including joint and limb pain, gastrointestinal distress, shortness of breath and abnormal 
menstruation, which negatively affected normal day to day functioning and quality of life 
2 
  
(Johnson et al., 2001). BN specifically increases the risk for heart attack and stroke, while both 
disorders increase the risk for musculoskeletal, pain and cardio-metabolic conditions (Kessler et 
al., 2013). Furthermore, both eating disorders, and even subclinical binge eating, have 
significantly higher comorbidity rates for other mental illnesses compared to those without 
disordered eating. Specifically, rates for mood and anxiety disorders including major depressive 
disorder, agoraphobia and obsessive-compulsive disorder, impulse control disorders including 
attention-deficit/hyperactivity disorder, and substance use disorders including alcoholism and 
drug dependence are significantly higher in this population compared to those without binge-
eating disorders (Javaras et al., 2008; Johnson et al., 2001; Kessler et al., 2013). 
 As a behavioral symptom of mental illness, binge eating is treated with psychosocial 
therapies including cognitive behavioral therapy, however these therapies are rarely successful 
six months post-treatment (McElroy et al., 2012). Pharmacological treatments are also available 
that include targeting many different neurotransmitter systems, including antidepressants, 
psychomotor stimulants, and opioid-receptor antagonists. However, these pharmaceuticals have 
their own specific sets of risks and side-effects depending on the drug, and like psychotherapy 
are not effective in all cases (Arnold et al., 2002; McElroy et al., 2015). Therefore, in order to 
effectively treat binge eating behavior, it is necessary to further investigate the neurological 
correlates of this behavior, with a goal of identifying novel therapeutic targets. 
1.1.1 Human studies 
 Human studies of binge eating tend to focus on epidemiology, treatment and the 
neurobiological correlates and potential underlying mechanisms for the behavior. Binge eating 
behavior typically manifests in young adulthood, with the age of onset typically ranging from 18 
to 20 years for BN, earlier compared to 20 to 25 years for BED (Hudson et al., 2007; Kessler et 
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al., 2013). Binge eating disorders are considered by some to be “culturally-bound” disorders, in 
that they are prevalent more in Western societies compared to others. Even so, there are still 
significant differences across Western nations in their lifetime prevalence, ranging from low 
incidences of 0.1% for BN and 0.7% for BED in Italy, compared to 2.0% for BN and 4.7% for 
BED in Brazil (Kessler et al., 2013). One consistency is that the prevalence rates for BED are 
typically higher than those for BN in most nations. Some studies have demonstrated strong sex 
differences in the prevalence of these disorders, especially for BN. The female-to-male gender 
ratio has been estimated as ranging from as low as 5:1 to as high as 20:1 (Pesce et al., 2015; 
Steinhausen & Jensen, 2015). This gender difference also exists for BED, although the female-
to-male ratio is much lower compared to BN, ranging from 2:1 to 6:1 (Ágh et al., 2015). It is 
possible that these gender differences can partly be explained by societal factors, including more 
pressure on women than men to be thin, or for women to more often seek help for their 
maladaptive behaviors (Davis, 2015). However, hormonal influences cannot be excluded, and 
there is some evidence that feeding patterns and preferences change with the menstrual cycle 
(Frye & Demolar, 1994; McNeil et al., 2013). For example, ratings of chocolate craving have 
been found to vary with the menstrual cycle, and cravings were associated with more 
maladaptive eating habits, including guilt and inability to control intake (Hormes & Timko, 
2011). 
 As previously mentioned, the main treatments for binge eating are therapist-led 
psychotherapy, medication or a combination of the two. Often, especially in the case of BED, 
clinically significant recovery is measured both by a reduction of binge eating as well as 
decreasing body weight, although weight loss may not be relevant in all cases (Mathes et al., 
2009; McElroy et al., 2015). Meta-analyses of the effectiveness of certain talk therapies, 
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including cognitive behavioral therapy and interpersonal therapy, have shown them to be 
effective in reducing binge frequency compared to wait-list controls. However, some studies 
report that the therapeutic efficacy to reduce binge eating frequency was less significant at 12-
month follow ups  compared to that immediately post-treatment, indicating that they are not 
universally effective over time (McElroy et al., 2015; Wilfley et al., 2002). Antidepressants 
including fluoxetine and citalopram have been shown to reduce the frequency of binge episodes 
as well as associated psychiatric concerns, however the rate of drop-out from drug trials remains 
relatively high, from 16 to 57% (Arnold et al., 2002; McElroy et al., 2003, McElroy et al., 2012). 
Stimulant drugs such as lisdexamphetamine have also been shown to reduce binge frequency, 
however as with the antidepressants and other drug interventions, the rates of symptom 
improvement generally decrease once the drug is discontinued (Mathes et al., 2009). Combining 
therapy with drug treatment is often more successful than either treatment alone, however due to 
the number of drugs to choose from, finding the most suitable one for each patient varies from 
case to case, and again treatment effects often reduce once therapy or medication ceases. 
 Because treatment is not always successful, it is necessary to further understand the 
mechanisms underlying binge eating in the brain in order to figure out better treatments. Genetic 
studies within humans have provided some insights to these putative mechanisms of binge eating 
behavior based on the correlations with certain biological findings. For example, many studies 
have focused on the role of genetic variation in the activity of dopamine neurons, as well as 
dopamine transporters and receptors. Those with either BN or BED have been shown to be more 
likely to have a certain polymorphism of the dopamine transporter gene compared to those 
without an eating disorder, implicating the mesolimbic dopamine system with binge eating 
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behavior (Bello & Hajnal, 2010). However, human studies are yet unable to fully uncover the 
complex interaction between binge eating behavior and the brain. 
1.1.2 Animal studies 
 Because the interconnected effects of binge eating and neuronal activity cannot be 
directly measured using human studies, animal models are necessary in order to use accurate, 
invasive methods of studying the neural associations of binge-like feeding. Animal models allow 
for the production, investigation and testing of binge-like models of food intake and the 
correlation of physiological parameters, including effects on the activity of neuronal populations. 
While it is difficult to measure subjective feelings in animal models that are a part of human 
binge eating, such as a loss of control or guilt, there are methods that can objectively test for 
factors such as anxious or depressive behaviors that may accompany binge-like feeding (Corwin 
& Buda-Levin, 2004). Due to the different behavioral phenotypes of the eating disorders, 
including variations in feeding frequency or self-imposed fasting, many different models have 
been generated in order to represent the variety of behaviors observed in each disorder. The 
common factor in modelling BN or BED is to promote binge-like feeding behavior in animals.  
 There are three common methods used to promote binge-like feeding behavior in 
animals, including using food restriction, stress, or intermittent exposure to palatable foods 
(Avena et al., 2008; Bake et al., 2014; Boggiano et al., 2007; Hagan et al., 2003; Pankevich et al., 
2010; Vickers et al., 2015). In food restriction paradigms, animals do not have ad libitum access 
to any food for a period of time, or a baseline of caloric intake is measured and only a fraction is 
allotted to each animal (Hagan & Moss, 1997; Pankevich et al., 2010). These models have the 
benefit of being able to mimic some forms of human eating disorders in which people self-
restrict their food intake, only to engage in subsequent binge episodes. However, because food 
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restriction results in the altered levels of many hunger and satiety signals, including ghrelin, 
leptin, glucose and a number of neuropeptides in the brain, the subsequent neuronal effects from 
binge eating may be indiscernible from the effects of food restriction, potentially confounding 
the results. Thus, food restriction may not be a suitable methodology for investigating specific 
effects of binge eating, depending on what variables related to binge eating are intended for 
study (Ahima et al., 1996; Kunii et al., 1999; Zhao et al., 2008). 
 Binge episodes in humans are often precipitated by stressful life events, thus animal 
models involving stress exposure are able to mimic these feeding patterns (Kessler et al., 2013). 
Stress-induced binge eating involves pairing some form of stress with access to highly palatable 
foods. Foot shock, noise, or maternal separation are some common stressors used in these studies 
(Boggiano et al., 2007; Iwasaki et al., 2000; Wilson & Cantor, 1987). Like food restriction, 
experience to stress results in changes in a number of feeding related signals. For example, 
glucocorticoids that are released during stress interact with insulin and leptin function, both 
hormones that in part modulate the membrane potential and activity of neurons in the arcuate 
nucleus of the hypothalamus that regulate feeding behavior (Gyengesi et al., 2010). Downstream 
effects of stress exposure itself, like food restriction, may confound the effects of binge eating on 
neuronal populations. Thus, using models of stress-induced binge-like behavior may be 
inappropriate depending on the variables under investigation. 
 A third common method to promote binge-like behavior involves using intermittent 
exposure to palatable foods (Babbs et al., 2012; Corwin et al., 1998; Iemolo et al., 2012). In the 
majority of these models, animals have free access to standard chow and water throughout the 
study. In addition, animals are given access to a palatable food, in most cases between 30 and 
120 minute episodes, daily, every other day, or three times per week on non-consecutive days 
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(Corwin et al., 1998; Dimitriou et al., 2000; Wojnicki et al., 2013).  After a number of exposures, 
animals typically exhibit binge-like behavior upon presentation of the food. These intermittent 
access models have the benefit of reducing the number of variables by omitting factors related to 
food restriction or stress. 
 Using animal models of binge eating, it is possible to experimentally tease out 
neurophysiological correlates of these behaviors in the brain that may be the cause or the result 
of binge-like eating. The following sections will review physiological and neural evidence 
gathered from human research and animal models in the study of the central control of normal 
food intake and binge-like feeding. 
1.2 Central control of feeding behavior 
1.2.1 Overview  
 Early research on food intake has identified various putative mechanisms by which it is 
controlled. For example, the “glucostatic theory” postulates that food intake is governed by the 
level of available energy for the body. Mayer suggested that when levels of available energy, 
specifically glucose, falls, a meal is initiated in order to replenish available energy (Mayer, 
1955). The “lipostatic theory” suggests that food intake is based not on levels of available 
glucose, but on levels of energy stored in the form of white adipose tissue (Kennedy, 1953). It 
has since become apparent that the regulation of energy balance is a complex process which 
integrates both central and peripheral neurobiological and endocrine signals with the 
environment. Simplistically, many of these signals can be thought of as either hunger 
mechanisms promoting food intake or satiety mechanisms that reduce food intake or terminate a 
meal. 
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 Internal hunger mechanisms include signals coming from the digestive tract as well as 
concentrations of substances within the blood. The hormone ghrelin, dubbed the “hunger 
hormone” is secreted by the stomach and duodenum when hungry, whereas its secretion is 
decreased by increasing levels of glucose, fatty acids and dietary fiber following food intake 
(Gormsen et al., 2006; Guo et al., 2008; Shiiya et al., 2002). Insulin, a hormone produced by the 
pancreas, is released following food intake to decrease blood glucose levels and initiate 
glycogenesis (Berg et al., 2002). Another hormone, leptin, is produced by white adipose tissue at 
a level proportional to the amount of white adipose tissue in the body (Considine et al., 1996). 
These hormonal signals of both satiety and hunger, such as insulin, leptin and ghrelin, are able to 
act on circumventricular organs outside the blood-brain-barrier or adjacent brain areas where 
neurons bear receptors for these chemicals (Golden et al., 1997). Following food intake, 
increases in insulin and leptin activate anorexigenic neurons and inhibit orexigenic neurons in 
the brain, suppressing appetite (Cowley et al., 2001; Qiu et al., 2014). On the contrary, when 
energy stores are metabolized in between meals, decreasing levels of insulin and an increase in 
ghrelin in part stimulate hunger and promote the initiation of food intake.  
 The specific role of the brain, and in particular the hypothalamus, in food intake was first 
hypothesized from patients suffering from Fröhlich's syndrome, a disorder characterized by low 
levels of gonadotropin releasing hormone that results from hypothalamic abnormalities 
(Copeman, 1927; Morgan, 1959). Patients with the disorder engaged in excessive feeding 
behavior, suggesting to clinicians that the hypothalamus played a significant role in food intake. 
Following this, brain lesioning in animal studies revealed regions of the brain involved with 
feeding. Damage to the ventromedial nucleus of the hypothalamus produced a voracious 
appetite, leading to it to be termed the “satiety center,” whereas lesions of the lateral 
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hypothalamic area produced the cessation of feeding behavior, leading to starvation and death 
(Brobeck et al., 1943). Thus, this led to the lateral hypothalamus being labelled the “feeding 
center” (Anand & Brobeck, 1951). In the years following these lesion studies, comparably more 
precise and refined electrical stimulation studies were conducted, in which specific brain regions 
were stimulated with electrodes. Animals would subsequently eat ravenously if stimulated at the 
lateral hypothalamus, furthering the idea that particular parts of the brain control certain aspects 
of ingestive behavior (Hoebel, 1969). Later, these regions of the brain would be found to contain 
receptors for the peripheral signals of satiety and hunger, thus providing mechanistic evidence as 
to how the brain and body interact to regulate food intake. 
In addition to homeostatic control of food intake, external food cues and psychological 
factors also play roles in hedonic control of feeding (Lutter & Nestler, 2009; Saper et al., 2002). 
Central control of homeostatic food intake occurs when metabolic signals indicating the need for 
energy are up- or downregulated, such as with leptin, ghrelin and other factors. On the other 
hand, hedonic food intake occurs outside the metabolic need for energy balance. It depends 
especially on external food cues such as the availability of palatable, calorie-rich food. Cues such 
as sight, smell or taste of food can stimulate brain regions involved with motivation and reward, 
promoting food intake for the pleasurable sensations it can provide (Amin & Mercer, 2016; 
Hussain & Bloom, 2012). 
1.2.2  Hypothalamic control of food intake 
 The hypothalamus is considered to be the homeostatic control center of the body, 
maintaining such processes as body temperature, fluid balance, sleep-wake cycles, and food 
intake. It also serves to modify behaviors in order to maintain homeostasis of these processes. 
The hypothalamus contains multiple nuclei with distinct neuronal populations that produce 
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unique neuropeptides that function to increase or decrease feeding related sensations and 
behaviors. As previously mentioned, lesioning and stimulation studies first brought to light the 
integral role of the hypothalamus in feeding behavior (Brobeck et al., 1943; Hoebel, 1969). 
These studies highlighted the paraventricular, arcuate and lateral hypothalamic regions as being 
specific regions related to satiety and hunger. These nuclei have significant reciprocal 
projections with each other and with other brain regions. Furthermore, the arcuate nucleus is 
located adjacent to circumventricular organs. This allows these nuclei to regulate feeding 
behavior and food intake based upon the levels of peripheral signals.  
 As previously stated, the maintenance of energy homeostasis and food intake can be 
thought of as a series of competing satiety and hunger signals integrated by the hypothalamus. 
The arcuate nucleus of the hypothalamus is the first to respond to changes in peripheral signals 
due to its proximity to circumventricular organs. These first order neurons include the orexigenic 
neuropeptide-Y and agouti related peptide (AgRP/NPY) expressing and the anorexigenic pro-
opiomelanocortin and  cocaine- and amphetamine-regulated transcript (POMC/CART) 
expressing neurons  (Cowley et al., 2001). Satiety signals such as leptin and insulin are increased 
following food intake, and decrease the activity of NPY/AgRP neurons and excite POMC/CART 
neurons (Cowley et al., 2001). Hunger signals like ghrelin have the opposite effect (Wang et al., 
2002). In addition, NPY has been shown to inhibit POMC/CART neurons, suggesting that 
complex interactions between peripheral signals and the interaction of these neuronal 
populations in part regulate hunger and satiety (Roseberry et al., 2004). 
 These key neurons of the arcuate nucleus have significant projections to second order 
neurons in other hypothalamic nuclei, including the lateral hypothalamus (Elias et al., 1999). The 
lateral hypothalamus contains neurons that produce orexigenic peptides, including the orexins 
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and melanin-concentrating hormone (MCH). Both the arcuate and lateral hypothalamic nuclei 
affect one another in promoting food intake. For example, administration of an NPY-Y1 receptor 
antagonist, BIBO3304, partially attenuated orexin-induced feeding, suggesting that 
communication between the two nuclei in part regulate food intake (Yamanaka et al., 2000). 
Furthermore, the lateral hypothalamus lies at the intersection of homeostatic and hedonistic 
feeding due to the nature of its reciprocal projections within the hypothalamus and outside 
regions, including significant projections with dopaminergic ventral tegmental area (VTA) 
neurons as well as the nucleus accumbens (Fadel & Deutch, 2002; Stratford & Kelley, 1999). 
Animals will lever press in order to receive electrical stimulation of the lateral hypothalamus, 
and electrical stimulation has also been shown to increase feeding behavior (Huston, 1971; 
Mogenson & Stevenson, 1966). Together, these are indicative of the dual role of the lateral 
hypothalamus in both central control of food intake as well as motivation and reward. 
1.2.3  Neurobiology of binge eating 
 The neurobiology of binge eating, unlike normal feeding behavior, may rely less on 
homeostatic mechanisms and may be modulated primarily by hedonic mechanisms. In terms of 
homeostatic factors, some have argued that episodes of binge eating are instances in which 
certain satiety mechanisms do not function properly, leading to a prolonged meal and excessive 
food intake (Blundell & Finlayson, 2004). Some studies have suggested abnormal levels of 
neuropeptides related to hunger and satiety, including lower basal or post-prandial levels of  
anorexic cholecystokinin and peptide YY, and decreased basal or increased post-prandial levels 
of ghrelin in those suffering from eating disorders compared to the general population (Geliebter 
et al., 2004; Monteleone et al., 2005). Another study addressing the same parameters had 
conflicting results, suggesting that the baseline levels of these hormones before a meal are 
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similar between groups. However, they found increased levels of meal-induced cholecystokinin 
and peptide YY in a binge eating population compared to weight-matched controls (Munsch et 
al., 2009). Considering the heterogeneity of feeding behaviors in binge-eating disorders, it is 
possible that the observed differences in peripheral signals are dependent on specific eating 
patterns and not binge-eating alone. Despite this, all forms of binge eating share a hedonic force 
driving the behavior. 
 The psychological motivation to eat primarily derives from the rewarding sensations 
provided by foods that are palatable, typically high in sugar and fat. This preference is partly 
mediated by the mesolimbic dopamine system and the endogenous opioid system. Rewarding 
sensations have long been associated with dopamine release from neurons in the VTA onto the 
nucleus accumbens, and palatable foods high in sugar or fat have been shown to stimulate this 
dopamine release (Avena et al., 2006; Rada et al., 2005; Rada et al., 2012). In addition, it has 
been shown in animal models that larger amounts of food result in a larger release of dopamine 
(Meguid et al., 1995). It is possible that the chronic release of dopamine from constant ingestion 
of foods high in sugar and fat modify the natural rewarding mechanisms of food intake, 
producing a feed-forward cycle of overeating, perhaps a similar mechanism observed in drug 
addiction (Alsiö et al., 2012). In addition to the release of dopamine, many studies have 
demonstrated that the hedonic consumption of sugars and fats is dependent on the activation of 
mu-opioid receptors, which have been correlated with feelings of pleasure, as well as being a 
factor involved with the intake of drugs of abuse (Chang et al., 2007; Colantuoni et al., 2001). 
 Binge eating has often been compared to drug addiction, with the first mention of so-
called “food addiction” taking place several decades ago (Randolph, 1956). Many of the DSM-5 
criteria for substance use disorders can be applied to those suffering from binge eating disorders, 
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including: use of larger amounts of drug, or food, over time; physical or psychological problems 
related to usage including negative affect or hangover effects; or spending excess time either 
engaging in the behavior or recovering from it, such that other obligations or activities are not 
met (Meule & Gearhardt, 2014; Smith & Robbins, 2013). This point of view in part led to the 
development of the Yale Food Addiction Scale, a diagnostic tool used to clinically assess the 
presence or severity of binge eating behavior in viewing it as an addictive behavior similar to 
drug abuse or compulsive gambling (Gearhardt, 2009). As previously mentioned, foods high in 
refined sugars and fats cause excessive dopamine release and activation of mu-opioid receptors 
in the brain, similar to commonly abused drugs such as nicotine, opiates and alcohol. Those with 
addictive disorders and those with binge eating disorders have also been shown to share similar 
genetic traits related to the dopamine system (Wang et al., 2001). In addition, psychosocial 
stressors often precipitate a binge episode, similar to how stress often precedes a drug binge 
(Hudson et al., 2007). Therefore, binge eating and addiction have similar behavioral and 
neurochemical properties. 
 However, binge eating also has aspects dissimilar to those of substance use disorders. 
The operational definitions of the disorders draw differences between the time frames of either a 
substance or food-related binge episode. Where drug use may be a near constant daily behavior, 
binge eating takes place in discrete periods of time, often lasting only a few hours maximum 
(Gearhardt et al., 2011). Furthermore, withdrawal and tolerance are two of the diagnostic criteria 
for substance dependence, whereas these criteria are not part of those for eating disorders in the 
DSM-5 (American Psychiatric Association, 2013). Nonetheless some studies have suggested that 
in animals trained to binge on palatable foods, administration of naloxone, an opioid receptor 
antagonist, produces measurable withdrawal symptoms such as tremor and anxiety, whereas 
14 
  
these effects were not present in control animals (Colantuoni et al., 2002). Others have suggested 
that not all people engaging in binge eating do so in the same way, classifying some people's 
binge eating as more “compulsive” or “addictive” in nature compared to that of others. For 
example, some people experience withdrawal-like symptoms such as negative affect, difficulty 
sleeping and inability to concentrate when not bingeing (Cassin & von Ranson, 2007). In 
summary, despite some differences, biological and psychological characteristics are highly 
similar between binge eating and substance dependence, which may suggest that these disorders 
are more alike than different. 
1.3 Orexin and MCH 
 The lateral hypothalamus contains the cell bodies of both orexin and MCH-producing 
neurons that mediate both reward and food intake based upon connections with other brain 
regions. Thus, it is highly likely that these neurons play a significant role in binge eating that 
involves hedonic control of food intake. In the adult rat, orexin neurons are located 
approximately 2.3mm to 3.7mm posterior from the bregma, and MCH neurons from 
approximately 2.1mm to 3.9mm (Nambu et al., 1999; Sapin et al., 2010). Both orexin and MCH 
neurons are found in the lateral hypothalamic area as well as the perifornical area, whereas MCH 
neurons also extend into the anterior regions of the zona incerta and more medial regions (Hahn, 
2010). These neurons project widely throughout the brain in order to regulate arousal, sleep, 
reward, stress, motivation and feeding behavior (Barson et al., 2013). A brief overview of some 
of the connections between these neurons and others regulating food intake and reward can be 
seen in Figure 1. 
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Figure 1. Overview of interactions between feeding and hedonic pathways 
Peripheral signals influencing food intake, such as circulating leptin and ghrelin, activate or 
inhibit anorexigenic and orexigenic neurons in the arcuate nucleus, respectively. Orexigenic 
neuropeptide Y/agouti related peptide (NPY/AgRP) neurons of the arcuate nucleus inhibit orexin 
neurons, as do local MCH neurons in the lateral hypothalamus. In turn, orexin neurons project to 
NPY/AgRP neurons. Food intake stimulates the release of dopamine from the ventral tegmental 
area onto the nucleus accumbens, and both regions share projections to and from the lateral 
hypothalamus, where dopamine can activate or deactivate orexin neurons depending on the 
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concentration of dopamine release, whereas orexin has excitatory effects on dopaminergic 
neurons. 
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1.3.1 Orexin 
 The orexin, or hypocretin, peptides were independently discovered  by two groups nearly 
twenty years ago (de Lecea et al., 1998; Sakurai et al., 1998). The name orexin derives from the 
Greek orexis, for appetite, while hypocretin is a portmanteau of hypothalamus and secretin, 
another neuropeptide that in part regulates water homeostasis. Orexins are produced by cleavage 
of the prepro-orexin peptide, resulting in orexin A and orexin B peptides. Orexin receptors are 
G-protein coupled receptors, OX1R and OX2R. Orexin A has equal affinities for both receptor 
types, whereas orexin B has a higher affinity for OX2R than OX1R. Orexin peptides are 
typically excitatory in nature, with activation of both orexin receptors resulting in an increase in 
intracellular calcium (Sakurai et al., 1998). While orexin neurons are only located in the lateral 
hypothalamus, they send extensive projections throughout the cerebrum and brainstem in order 
to regulate many functions. For example, orexins’ projections to noradrenergic neurons of the 
locus coeruleus in part maintain arousal, and projections to the limbic system mediate mood 
(Hagan et al., 1999; Winsky-Sommerer, 2004). Injections of orexin A into the lateral ventricles 
have also been shown to promote anxiety-like behaviors compared to saline control, implicating 
orexin activity with the stress system (Suzuki et al., 2005). 
Orexins have been shown to play a positive role in food intake, particularly the intake of 
palatable foods. Injection of orexin-A directly into hypothalamic nuclei including the lateral 
hypothalamus and paraventricular nucleus, as well as the nucleus accumbens, have been shown 
to promote intake of standard chow in sated rodents (Dube et al., 1999; Thorpe & Kotz, 2005). 
This effect has also been demonstrated when the food is palatable, and specifically increased 
consumption of a high fat food over a high carbohydrate food (Clegg et al., 2002). Furthermore, 
intraperitoneal administration of the OX1R antagonist SB-334867 preferentially decreases intake 
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of palatable high fat food in sated rats compared to vehicle injection, implicating that orexin 
activity may be necessary for hedonic food consumption (Choi et al., 2010). 
 The role of orexins in modulating feeding behavior is also partly based on orexin 
neurons’ connections with other hypothalamic neurons regulating feeding. Orexins activate 
orexigenic NPY/AgRP neurons of the arcuate nucleus, whereas NPY inhibits orexin neuron 
firing (Fu, 2004; Yamanaka et al., 2000). NPY/AgRP neurons are directly responsive to 
peripheral signals such as leptin and ghrelin, thus orexin neurons are also downstream targets of 
these peripheral signals of hunger and satiety.  
Orexin neurons also have projections to the VTA and the nucleus accumbens. Orexin 
peptides activate dopaminergic neurons of the VTA, as well as neurons of the nucleus 
accumbens shell, suggesting a role for orexins in reward and motivation (Korotkova et al., 2003; 
Mukai et al., 2009). On the other hand, our lab previously demonstrated that dopamine 
modulates GABAergic transmission to orexin neurons, disinhibiting them at low concentrations 
and inhibiting activity at higher concentrations (Linehan et al., 2015).  
Given its connection with the VTA dopaminergic system, it is no surprise that orexins 
have been shown to play a role in substance dependence. Orexin-A injection results in 
reinstatement of drug seeking in addiction models, including alcohol and nicotine dependence 
(Lawrence et al., 2006; Plaza-Zabala et al., 2010). Conversely, orexin knock-out mice display a 
lower intensity of morphine dependence and opioid antagonist-induced withdrawal symptoms 
following repeated morphine exposure than wildtype mice, implicating orexin neurons in the 
development of substance dependence (Georgescu et al., 2003).  
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Similar effects have been noted for palatable food intake. Orexin injection into the fourth 
ventricle increases progressive ratio response for sucrose in rats, whereas injection of the OX1R 
antagonist SB334867 prevented the acquisition of a high-fat-induced conditioned place 
preference (Kay et al., 2014). Additionally, SB334867 administration reduced the cue-induced 
reinstatement of sucrose-seeking in food restricted rats (Cason & Aston-Jones, 2014). Finally, in 
a mouse model of binge-like consumption of sucrose or saccharin solutions, intraperitoneal 
administration of SB334867 significantly decreased the intake of these solutions without altering 
arousal as measured by locomotion (Alcaraz-Iborra et al., 2014). Considering the similarities 
between substance dependence and binge eating and the role orexins play in both food intake and 
drug dependence, these findings suggest a role for orexin activity in binge-like feeding behavior. 
1.3.2 Melanin-concentrating hormone (MCH) 
 MCH was first discovered in the pituitary of teleost fishes as a factor that prevents 
changes in skin pigment by acting as an antagonist of alpha-melanocyte stimulating hormone 
(Kawauchi et al., 1983). Following this, the peptide was identified in the hypothalamus of 
rodents, and was found to be the natural ligand of an orphan receptor (Chambers et al., 1999). 
There are two isoforms of MCH receptor identified, MCH1R which is found in all vertebrates, 
and MCH2R which is found only in certain mammalian species, including humans, dogs, ferrets 
and others (Tan et al., 2002). MCH has been demonstrated as playing a role in sleep wake cycles, 
depressive behaviors, and food intake (García-Fuster et al., 2012; Qu et al., 1996; Verret et al., 
2003). MCH receptor activation generally results in decreased neuronal activity, and MCH has 
been shown to reduce the activity of neighboring orexin neurons (Gao & Van Den Pol, 2001; 
Rao et al., 2008). However, repeated intracerebroventricular MCH administration resulted in an 
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increase in NPY gene expression, suggesting that MCH may activate other orexigenic neurons of 
the hypothalamus (Della-Zuana et al., 2002). 
Like orexin neurons, MCH neurons project widely across the brain, although the effects 
of MCH can be considered complementary, and sometimes opposite, to those of orexin. Where 
orexin promotes energy expenditure and wakefulness, the MCH system has been shown to have 
a negative effect on energy expenditure, as can be seen in the hyperactive phenotypes of animals 
with MCH knockout (Alon and Friedman, 2006). Indeed, MCH neurons are relatively silent 
during wakefulness and display spontaneous firing activity during REM sleep (Hassani et al., 
2009). However, both peptide systems have been linked to states of stress. Administration of 
MCH produces anxiety-like behaviors in rats as measured by behaviors in the elevated plus 
maze, whereas the MCH1R antagonist GW3430 attenuates the anxiogenic effects of MCH when 
co-administered, and produces anxiolytic effects when administered alone (Smith et al., 2005). 
Furthermore, MCH neurons have also been implicated in reward and motivation. The nucleus 
accumbens shell, a prominent structure in reward and addiction, has a dense concentration of 
MCH1R receptors, strongly suggesting a role in reward (Saito et al., 2001). Activation of the 
MCH1R receptor has been shown to potentiate cocaine-induced increases in locomotion, and 
blockade or knockout of these receptors results in reduced response to cocaine and conditioned 
place preference (Chung et al., 2009). 
Also similar to orexin neurons, MCH neuron activation increases palatable food 
consumption, and palatable foods in turn activate MCH neurons (Gomori et al., 2003). While 
MCH has been shown to promote food intake, antagonism of MCH1R has been shown to reduce 
the conditioned responses and reinstatement for sucrose-seeking (Karlsson et al., 2012). Also, 
compared to wildtype controls, MCH1R knockout mice display decreased levels of overeating 
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when presented with a conditioned stimulus for sucrose availability, suggesting MCH plays a 
role in non-homeostatic feeding (Sherwood et al., 2015). Considering the roles that both orexin 
and MCH neurons have in food intake and addictive behaviors, it is possible that both groups of 
neurons play significant roles in the development or maintenance of binge-like feeding 
behaviors. 
1.4 Rationale and Objectives 
 Because binge eating is a hedonic form of feeding that parallels addiction, it likely 
involves the reward system and food intake control center. Orexin and MCH neurons are 
important regulators of food intake and the reward system. Therefore, I hypothesized that these 
neural populations are functionally altered in a rat model of binge-like feeding in a manner that 
promotes binge eating. This thesis tested this hypothesis by examining the electrophysiological 
properties of both orexin and MCH neurons in rats displaying binge-like feeding on palatable 
diets. 
Objective 1 – Establishing an animal model of binge eating 
 In order to investigate any possible correlations of altered function of orexin or MCH 
neurons in binge-like feeding, a reliable, robust animal model of binge eating is necessary. 
Because both food restriction and physical stress may have direct and indirect effects on orexin 
and MCH neurons irrespective of binge eating, I utilized an animal model of binge eating using 
intermittent access to palatable foods. 
Objective 2 – Characterize orexin and MCH neurons in the binge eating model 
 To determine functional changes of these neurons associated with binge eating, in-vitro 
electrophysiological recordings were performed. This research may represent the first 
22 
  
electrophysiological study of orexin and MCH neurons following induction of binge-eating 
behavior in rats. Any associated changes may represent unique mechanisms that underlie binge 
eating, which can lead to the development of novel treatments for binge eating disorders.  
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Chapter 2 - Materials and Methods 
All experiments were conducted in accordance with the guidelines of the Canadian Council on 
Animal Care, under the approval of the Memorial University Institutional Animal Care 
Committee. 
2.1 Animal Models 
 Male and female 3 to 4 week old Sprague-Dawley rats (40-100g) were obtained from the 
breeding colony of Memorial University. Rats were singly housed and acclimatized for 3 days 
before the feeding paradigms started in a temperature and light controlled room (12:12h light-
dark schedule, with lights on from 8:00 am to 8:00 pm) within the animal care facility in the 
Health Sciences Centre. Chow (Prolab RMH 3000) and water were provided ad-libitum. For ad 
libitum feeding, chow was placed on the food hopper.  
2.1.1 Intermittent palatable diet feeding paradigms 
1-week daily feeding (1wDaily) paradigm: following acclimatization, rats were allowed in-cage 
access from 2:00 pm to 3:00 pm on 6 to 11 consecutive days to one of three diets: standard chow 
(29.8% protein, 13.4% fat, 56.7% carbohydrate; 3.08kcal/g), a high fat diet (HFD) (Research 
Diets D12492, 20% protein, 60% fat, 20% carbohydrate; 5.24kcal/g), and a “western diet” (WD) 
high in sugar and fat (Test Diet AIN76-A, Western Diet, 15.5% protein, 40.1% fat, 44.4% 
carbohydrate; 4.49kcal/g).  
2-week Monday, Wednesday, Friday feeding paradigm (2wMWF):  Following acclimatization, 
rats had 1-hour in-cage access from 2:00 pm to 3:00 pm to a known amount of one of two diets, 
chow or HFD on Mondays, Wednesdays and Fridays (MWF) for a total of 6 to 9 in-cage food 
exposures.  
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 6-week MWF feeding paradigm (6wMWF): This paradigm followed the same weekly 
schedule as the 2wMWF feeding paradigm, except rats were given at least 18, up to 26 in-cage 
food exposures.  
For all animals, the in-cage diets were removed following the one hour exposure and 
weighed with a digital scale in order to assess the amount of the diet consumed. Daily chow 
intake from the food hopper was also measured at this time. Caloric intake from the in-cage food 
and chow in the hopper were calculated from the weight of food that disappeared and the caloric 
density of each food. Total daily caloric intake was the sum of calories consumed from the two 
sources of food. A percentage of caloric intake from intermittent exposure to in-cage food was 
calculated by dividing the calories consumed from intermittent feeding by the total daily caloric 
intake. This percentage of total caloric intake consumed during the 1-hour feeding was used as a 
measure of binge-feeding intensity. Initial body weights were measured upon arrival and final 
body weights for each rat were recorded prior to sacrifice. 
2.2 In-vitro electrophysiology 
2.2.1 Slice Preparation 
 Each rat was sacrificed the morning following their final 1-hour food exposure. Rats were 
anaesthetized with isoflurane and decapitated, and the brains removed, trimmed, and placed in a 
vibratome (Leica Microsystems VT1000S) chamber filled with ice-cold buffer solution perfused 
with 95%O2/5%CO2, containing (in mM): 87 NaCl, 2.5 KCl, 25 NaHCO3, 7 MgCl2, 1.25 
NaH2PO4, 25 glucose, 30 sucrose, 3 pyruvic acid, 1 ascorbic acid, 0.5 CaCl2. Slices were 
coronally sectioned at 250µm and then incubated for 30 minutes in 32-34°C artificial 
cerebrospinal fluid (ACSF) perfused with 95%O2/5%CO2, containing the following (in mM): 
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119 NaCl, 2.5 KCl, 1.2 NaH2PO4, 1.2 MgCl2, 25 NaHCO3, 2.5 glucose, 1 ascorbic acid, 0.5 
CaCl2. Following this, slices were maintained at room temperature in ACSF perfused with 
95%O2/5%CO2 until patch clamp electrophysiology. 
2.2.2 Whole-cell patch-clamp 
 Hemisected slices were placed in a recording chamber with ACSF bubbled with 
95%O2/5%CO2 perfused at 1.5-2.5 mL/min at 26-28°C under an infrared-differential interference 
contrast microscope (DM LFSA Leica Microsystems). Whole-cell patch-clamp experiments 
were conducted using a Multiclamp 700B amplifier and pClamp 9.2 and 10.3 software 
(Molecular Devices). The recording pipettes had a tip resistance between 3-6MΩ when filled 
with internal solution containing the following (in mM): 123 K-gluconate, 2 MgCl2, 8 KCl, 0.2 
EGTA, 10 HEPES, 4 Na2-ATP, 0.3 Na-GTP, 7.3pH. The internal solution also included 2.2mM 
biocytin for post-hoc immunohistochemistry. 
 Voltage-clamp mode at -70mV was used to form a gigaohm seal before breaking into the 
cell, at which point membrane capacitance, membrane resistance, and access resistance were 
measured and recorded. Neurons with membrane resistance below 200MΩ or access resistance 
above 20 MΩ were excluded from analysis. Current-clamp mode was used to identify putative 
orexin and MCH neurons by their electrophysiological responses to hyperpolarizing and 
depolarizing current steps ranging from -200pA to 200pA in 50pA increments. These recordings 
were also used to assess resting membrane potential, latency to first spike, threshold, and elicited 
action potential frequency. A current ramp protocol was also used which injected current from 
0pA to 100pA or 200pA over five seconds. Resulting responses were used to assess rheobase, or 
the minimum current injection necessary to elicit an action potential, and elicited action potential 
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frequency.  Recordings were digitized at 20kHz in Clampex, and at 1kHz in Axoscope, and 
stored for off-line analysis. 
2.2.3 Post-hoc immunohistochemistry of recorded cells 
 Following patch-clamp, brain slices were placed in 10% formalin (Sigma Aldrich) at 
least overnight, then washed three times for ten minutes in phosphate buffer solution (PBS). 
Primary antibodies were prepared by diluting anti-Orexin A goat polyclonal IgG (1:2000 
dilution; Santa Cruz Biotechnology) and anti-MCH rabbit polyclonal IgG (1:2000 dilution; 
Phoenix Pharmaceuticals) in PBS with 0.3% Triton-X (Fisher Scientific). After washing, slices 
were placed in a 96-well plate and submerged in 70µL of the primary antibody solution, covered, 
and kept at 4°C for 72 hours. Following incubation with primary antibodies, slices were washed 
again in PBS. Secondary antibody cocktail contained 1:500 donkey anti-goat Alexa Fluor 488 
(Invitrogen), 1:500 donkey anti-rabbit Alexa Fluor 594 (Invitrogen) and 1:500 streptavidin Alexa 
Fluor 350 (Life Technologies). Slices were incubated in secondary antibodies in dark, overnight 
at 4°C. After incubating in secondary antibodies, sections were again washed in PBS and 
mounted onto glass slides with Dako Fluorescent Mounting Medium (Dako, Agilent 
Technologies). Slices were then assessed under a fluorescence microscope to determine whether 
biocytin-labelled cells were positive for orexin A or MCH peptide. A small number of patched 
cells without clear biocytin-labelling (24 of 152 orexin neurons, or 15.8%; and 9 of 51 MCH 
neurons, or 17.6%) were included in the analysis based upon their electrophysiological responses 
to hyperpolarizing and depolarizing currents. 
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2.3 Data Analysis 
 Electrophysiological data was analyzed using Clampfit 9.2 and 10.3, (Molecular 
Devices). All data are expressed as mean ± standard error, where n represents the total number of 
cells per group. Statistical analysis was performed for feeding, body weight and 
electrophysiological data using appropriate tests in GraphPad Prism 6 software (GraphPad 
Software). Student’s t tests, one-way or repeated measures two-way ANOVA were used to 
analyze group data. Multiple comparisons were made using the Sidak test where appropriate. 
Statistical significance was chosen as p<0.05. 
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Chapter 3 - Results 
3.1 Behavioral responses to intermittent palatable food exposures 
3.1.1 Feeding Behavior of male 1wDaily access group 
 In order to determine whether a 1-hour intermittent feeding paradigm induces binge-like 
feeding behavior, rats were given 1h-access daily to control diet (chow, n=11), 60% high fat diet 
(HFD, n=16) or western diet (WD, n=6), and caloric intake from these diets was measured daily. 
Compared to the chow group, the HFD group consumed more calories during the one-hour 
feeding period on each day of intermittent exposure, whereas the WD group consumed more 
calories from day 2 onward, and this amount increased over elapsed days (Fig 2A, main effect of 
diet p<0.0001; main effect of elapsed days p<0.0001; interaction, p<0.0001; two-way ANOVA). 
The groups consumed different amounts of calories from chow from the food hopper (Fig. 2B, 
main effect of diet, p<0.0001; main effect of elapsed days, p<0.05; interaction p<0.001; two-way 
ANOVA). Multiple comparisons revealed that control and WD groups consumed a comparable 
amounts of hopper chow during the study, however the HFD group consumed less chow on the 
first (p<0.05), third (p<0.001), fourth (p<0.001), fifth (p<0.001) and sixth days (p<0.0001) day 
compared to chow control. This decrease is likely to be compensatory, because as mentioned 
above, the amount of HFD consumption significantly increased with repeated daily exposures 
within groups, whereas the chow group consistently consumed similar amount of calories during 
the 1h period on consecutive days. All groups consumed a similar amount of total calories 
throughout the 6-day feeding period, but this amount changed with time (Fig. 2C, effect of diet, 
p>0.05; main effect of elapsed days, p<0.0001; interaction, p>0.05, two-way ANOVA).  Both 
the HFD and WD groups consumed a substantial proportion of their daily caloric intake from the 
palatable diets during the 1-hour exposure compared to chow control, and this proportion 
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increased over time (Fig. 2D, main effect of diet, p<0.0001; main effect of elapsed time, 
p<0.0001; interaction, p<0.0001; two-way ANOVA). We compared the percent of total daily 
intake during the 1-hour food exposure during the latter half of the food exposure between the 
three groups as a measure of the plateau of binge-like feeding. There was a significant difference 
between the groups (Fig. 2E, p<0.0001, chow mean=5.1±2.7%, HFD mean=27.1±8.5% and WD 
mean=17.9±2.9%, one-way ANOVA), and multiple comparisons revealed a difference between 
chow and HFD (p<0.0001), chow and WD (p<0.01) and HFD and WD (p<0.05). This suggests 
that both HFD and WD access groups engaged in binge-like behavior, and it was more robust in 
the HFD group. 
 Initial body weights were taken for a subsample of the chow (n=10) and HFD (n=9) 
group, and there was no significant difference between the groups (Fig. 3A, chow=86.4±3.1g, 
HFD=74.8±5.2g, p>0.05, Student’s t-test). Body weight gain was also compared between the 
two groups, and again there was no significant difference between groups (Fig. 3B, 
chow=87.2±6.8g, HFD=91.6±11.5g, p>0.05, Student’s t-test). 
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Figure 2.  1wDaily intermittent palatable diet access induces binge-like feeding 
A. Caloric intake from food provided in-cage for 1h.  B.24h intake of chow provided ad libitum 
via a food hopper. C. Daily total calorie intake was calculated as a sum of 24h-intake of chow 
provided ad libitum and 1h-intake of chow, HFD or WD. D. Percentage of calories consumed 
during the 1h access to chow, HFD or WD with respect to total daily caloric intake. E. Average 
of the proportion of caloric intake from 1h access to chow, HFD or WD with respect to total 
caloric intake from their respective plateaus. Chow, black closed circles (n=11), HFD, gray 
closed circles (n=16) and WD, open circles (n=6). * for control vs HFD, *p<0.05, **p<0.01, 
****p<0.0001 + for control vs WD, +p<0.05, ++p<0.01, +++p<0.001, ++++p<0.0001  
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Figure 3. 1wDaily access to HFD does not alter body weight gain 
A. Initial body weights for a subsample of rats in 1wDaily chow (n=10) and HFD (n=9) groups. 
B. Body weight gain was calculated as initial weight subtracted from final weight before 
sacrifice. 
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3.1.2 Feeding behavior of male 2wMWF feeding group (3 access/week) 
Previous literature suggests that both daily intermittent diet access (Bake et al., 2014; 
Kelley et al., 2003) and diet access three times per week (MWF) (Corwin et al., 1998; de Jong et 
al., 2013) are able to induce binge-like behavior. Some studies suggest that intermittent access in 
MWF schedule results in greater binge-like behavior (Babbs et al., 2012; Corwin et al., 1998; 
Dimitriou et al., 2000). Therefore, we decided to use an alternative feeding schedule to assess 
whether it can produce more robust binge-like behavior as measured by the percent of total daily 
calories from HFD, or whether the time course of behavioral responses changes. We chose to test 
HFD and exclude WD from this paradigm, since HFD produced stronger binge-like behavior 
than WD in the 1wDaily feeding model. To test for any differences between the patterns of HFD 
exposure, i.e. daily or three times a week on non-consecutive days, the number of intermittent 
HFD access periods was matched to that of the 1-week group. 
The chow (n=4) and HFD-fed (n=4) groups consumed a different amount of calories 
during the 1h feeding period, which increased over time (Fig. 4A, main effect of diet, p<0.01; 
main effect of number of exposures, p<0.0001; interaction, p<0.0001, two-way ANOVA). 
Multiple comparisons revealed that the amount of caloric consumption during the 1h period 
significantly increased with repeated exposures, resulting in significantly different caloric intake 
during the 1h feeding period from the second exposure onward. Both groups consumed a similar 
number of calories from chow from the hopper during the study (Fig. 4B, effect of diet, p>0.05; 
effect of number of exposures, p>0.05; interaction, p>0.05; two-way ANOVA), and total daily 
caloric intake was not different between the chow control and HFD groups (Fig. 4C, effect of 
diet, p>0.05; effect of number of exposures, p>0.05; interaction, p>0.05; two-way ANOVA). 
The HFD group consumed a larger percentage of their calories during the 1-hour food exposure, 
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which increased with successive exposures (Fig. 4D, main effect of diet, p<0.01; main effect of 
number of exposures, p<0.01), interaction, p<0.01; two-way ANOVA). The chow group 
consistently consumed fewer calories during the 1h exposure. 
To better characterize the feeding behavior, we asked whether 1h bingeing on HFD 
influenced the chow intake on the same day as well as subsequent days. Specifically, we 
compared the total chow consumed on binge days (1h exposure to HFD) with those on the 
subsequent day (non-binge day). The rats consumed a similar amount of chow from the hopper 
on binge day compared to the subsequent day (Fig. 5A, effect of day, p>0.05; main effect of 
number of exposures, p<0.0001; interaction, p>0.05; two-way ANOVA). Overall, 1h access to 
HFD had no significant effect on total calories consumed (Fig. 5B, no effect of day, p>0.05; 
main effect of number of exposures, p<0.0001; interaction, p<0.01; two-way ANOVA), however 
multiple comparisons revealed that the total calories consumed on the day of the sixth 
intermittent access were greater than those of the following day (p<0.05).   
In order to assess the effect of binge-like feeding on body weight, body weights were 
measured at day one and on the final day. There were no differences in initial body weight of 
chow (67.2g±1.8g) and HFD groups (67.2g±0.8g) (Fig. 6A, p>0.05, Student’s t-test), or in the 
total body weight gain of chow (247.5g±15.1g) and HFD (269.0g±16.6g) groups (Fig. 6B, 
p>0.05, Student’s t-test). 
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Figure 4. 2wMWF intermittent HFD access induces binge-like feeding. 
A. Caloric intake from food provided in-cage for 1h. B. 24h intake of chow provided ad libitum 
via a food hopper. C. Daily total calorie intake was calculated as a sum of 24h-intake of chow 
provided ad libitum and 1h-intake of chow or HFD. D. Percentage of calories consumed during 
the 1h access to chow or HFD with respect to total daily caloric intake. Chow, closed black 
diamonds (n=4); HFD, open grey diamonds (n=4). *p<0.05, **p<0.01, ***p>0.001, 
****p<0.0001. Black arrowheads represent 1h in-cage food exposures.  
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Figure 5. 2wMWF in-cage chow or HFD access does not alter food intake between binge 
day and the subsequent day 
A. For HFD group, total daily caloric intake on binge day consisted of calories from hopper 
chow plus calories from in-cage HFD. Total caloric intake on the subsequent day was only 
calories from hopper chow. B. Chow intake from the hopper on binge day versus the subsequent 
day. Binge day, open grey diamonds, closed line; subsequent day, closed black squares and 
dashed line. **p>0.01. 
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Figure 6. 2wMWF access to HFD does not alter body weight gain 
A. Initial body weights for 2wMWF chow (n=4) and HFD (n=4) groups. B. Body weight gain 
was calculated as initial weight subtracted from final weight before sacrifice. 
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3.1.3 Comparison of behavioral response to different frequency of intermittent palatable 
food exposures 
 Literature suggests that greater intervals of intermittent feeding result in greater binge-
like behavior (Corwin et al., 1998; Wojnicki et al., 2013), so we compared these two groups with 
different feeding intervals to determine whether binge eating was more intense in 2wMWF 
paradigm with longer intervals between feeding episodes than the daily schedule. 
 We found no difference overall in the calories consumed between one-week and two-
week groups (Fig. 7A, main effect of feeding schedule, p>0.05; main effect of number of 
exposures, p<0.0001, interaction, p<0.01; two-way ANOVA), although multiple comparisons 
revealed a significant difference on the sixth day, with rats on 1-week daily feeding paradigm 
(13.7±1.4kcal) consuming less than those on two-week MWF paradigm (24.7±3.9kcal) (p<0.01). 
Nonetheless, there was no significant difference between the two groups in the total percent of 
calories obtained from HFD (Fig. 7B, main effect of feeding paradigm, p>0.05; main effect of 
number of exposures, p<0.0001; interaction, p>0.05; two-way ANOVA). Furthermore, multiple 
comparisons revealed no differences between the groups (p>0.05 on each number of exposure). 
This suggests that by the end of their respective intermittent feeding paradigms, both groups 
engaged in binge-like behavior of a similar magnitude. 
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Figure 7. Two schedules of intermittent HFD access promote similar feeding behaviors 
A. Total calories from HFD in the 1wDaily (n=16) and 2wMWF (n=4) groups. B. Percent of 
daily calories from HFD in the 1wDaily and 2wMWF groups. 1wDaily HFD, closed grey circles; 
2wMWF HFD, open grey diamonds. **p>0.01. 
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3.1.4 Feeding behavior of male 6wMWF (3 access/week) 
 Next, we decided to determine whether more repetition would lead to a more severe 
binge eating behavior. This time, we extended the MWF paradigm to six weeks, so that the 
number of intermittent accesses to HFD increased from six to eighteen. 
 The HFD group consumed more calories during the intermittent feeding than control 
group, and HFD intake increased over time (Fig. 8A, main effect of diet diet, p=0.0001; main 
effect of number of exposures, p<0.0001; interaction, p<0.0001; two-way ANOVA). However, 
the HFD group consumed less chow than the control group overall (Fig, 8B, main effect of diet, 
p<0.05, main effect of number of exposures, p<0.0001; interaction, p<0.0001; two-way 
ANOVA).  As a result, both chow control and HFD group consumed a similar amount of total 
calories throughout the experiment (Fig. 8C, effect of diet, p>0.05; main effect of number of 
exposures, p<0.0001; interaction, p<0.01; two-way ANOVA). Again, the HFD group 
progressively consumed a larger proportion of calories during the 1h intermittent food access 
than control group (Fig. 8D, main effect of diet, p<0.0001; main effect of number of exposures, 
p<0.01; interaction, p<0.01; 2-way ANOVA) which plateaued after the third exposure  
 Like the 2wMWF group, we compared the total calories and calories from chow 
consumed on the feeding day to the day after in the HFD group. We found that they consumed 
less calories from chow on the binge day (Fig. 9A, main effect of day, p<0.05; main effect of 
number of exposures, p<0.0001; interaction, p>0.05 two-way ANOVA), but the total calories 
consumed was similar on binge days as the subsequent days (Fig. 9B, effect of day, p>0.05; 
main effect of number of exposures, p<0.0001; interaction, p>0.05; two-way ANOVA). Thus, 
even though the animals display binge-like behavior upon HFD exposure, they are able to 
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compensate for the excess calories consumed from HFD by reducing chow intake, suggesting 
that their homeostatic control is intact.  
 We also compared the initial body weights and body weight gain (Fig. 10B) between 
chow (n=7) and HFD (n=7) 6wMWF groups. There was no difference in initial body weights 
(Fig. 10A, chow=77.2±2.6g, HFD=70.0±3.9g, p>0.05, Student’s t-test) or in body weight gain 
(Fig. 10B, chow=434.8±15.1g, HFD=382.1±30.2g, p>0.05, Student’s t-test). 
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Figure 8. 6wMWF intermittent HFD access induces binge-like feeding in male rats. 
A. Caloric intake from food provided in-cage for 1h.  B. 24h intake of chow provided ad libitum 
via a food hopper. C. Daily total calorie intake was calculated as a sum of 24h-intake of chow 
provided ad libitum and 1h-intake of chow or HFD. D. Percentage of calories consumed during 
the 1h access to chow or HFD with respect to total daily caloric intake. Chow (n=7), open white 
circles; HFD (n=7) closed blue circles. *p<0.05, **p<0.01, ***p>0.001, ****p<0.0001. Black 
arrowheads represent 1h in-cage food exposures. 
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Figure 9. 1h access to HFD has a short-term inhibitory effect on chow intake  
A. For the HFD (n=7) group, total daily caloric intake on binge day consisted of calories from 
hopper chow plus calories from in-cage HFD. Total caloric intake on the subsequent day was 
only calories from hopper chow. B. Chow intake from the hopper on binge day versus the 
subsequent day. Binge day, closed blue circles and closed line; subsequent day, open squares and 
dashed line. *p>0.05. 
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Figure 10. 6wMWF access to HFD does not alter body weight gain in male rats 
A. Initial body weights for 6wMWF chow (n=7) and HFD (n=7) groups. B. Body weight gain 
was calculated as initial weight subtracted from final weight before sacrifice. 
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3.1.5 Comparison of behavioral response to different number of intermittent palatable 
food exposures 
 In order to assess whether the magnitude of binge-like feeding would increase with a 
greater number of HFD exposures, we compared the percent of daily intake from HFD during the 
last three exposures for the 1wDaily, 2w- and 6wMWF groups. We chose the final three 
exposures because the intake was the greatest at these time points. There was no significant 
difference in the proportion of total calories coming from HFD between any group (Fig. 11, 
p>0.05, 1wDaily mean=27.1±8.5%, 2wMWF mean=25.1±6.5%, 6wMWF mean=26.8±6.1%, 
one-way ANOVA), suggesting that each schedule produced similar plateau of binge-like 
behavior 
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Figure 11. 1wDaily, 2wMWF and 6wMWF intermittent access to HFD promote similar 
magnitudes of binge eating 
Mean percentage of calories consumed during the 1h access from HFD with respect to total daily 
caloric intake in the last three HFD exposures for 1wDaily (27.1%, n=16), 2wMWF (25.1%, 
n=4) and 6wMWF (26.8%, n=7). 
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3.1.6 Feeding behavior of female 6wMWF group (3 access/week) 
 The literature suggests that binge-like behavior occurs more often in females than males 
(Hudson et al., 2007; Kessler et al., 2013). However, it is unclear whether this is due to 
psychosocial factors intrinsic to humans or biological differences between males and females. 
Therefore, we sought to determine whether there are any sex differences in binge-like behavior 
in our rat model. 
 Using the 6-week, three access a week paradigm, we found that the female HFD group 
consumed significantly more calories during intermittent HFD access than female control chow 
group and the calories consumed increased over time (Fig. 12A, main effect of diet, p<0.0001; 
main effect of number of exposures, p<0.0001; interaction, p<0.0001; two-way ANOVA). In 
contrast, the control group consumed significantly more calories from standard chow over 24h, 
than the HFD group (Fig. 12B, main effect of diet, p<0.05; main effect of number of exposures, 
p<0.0001; interaction, p<0.001; two-way ANOVA). Taken together, female control (n=7) and 
HFD group (n=6) consumed a similar amount of total daily calories (Fig. 12C, main effect of 
diet, p>0.05; main effect of number of exposures, p<0.0001; interaction, p<0.001; two-way 
ANOVA), but the HFD group consumed a higher proportion of daily calories during the 
intermittent feeding period than control group (Fig. 12D, main effect of diet, p<0.001; main 
effect of number of exposures, p<0.0001; interaction, p<0.01; two-way ANOVA). 
 The female HFD group consumed similar amounts of calories from hopper chow on 
binge days as subsequent days (Fig. 13A, main effect of day, p>0.05; main effect of number of 
exposures, p<0.0001; interaction, p>0.05; two-way ANOVA). Furthermore, they consumed 
similar amounts of total calories on the binge days as the subsequent days (Fig. 13B, main effect 
of day, p>0.05; main effect of number of exposures, p<0.0001; interaction, p<0.05; two-way 
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ANOVA). This indicates that while HFD animals consumed similar amounts of chow on binge 
days as well as the subsequent days, overall they consumed less chow than the control group. 
These results contrast with those found in the male 6wMWF group, suggesting that intermittent 
HFD access affects male and female feeding behavior differently. 
 Like the males, we compared the initial body weights and body weight gain between 
female chow (n=6) and HFD (n=7) 6wMWF groups. There was no difference in initial body 
weights (Fig. 14A, chow=68.4±5.2g, HFD=72.8±1.5g, p>0.05, Student’s t-test) or in body 
weight gain (Fig. 14B, chow=194.7±7.4g, HFD=193.8±12.0g, p>0.05, Student’s t-test). 
 In order to assess any sex-specific differences in feeding and binge-like behavior, we 
compared the male and female 6wMWF HFD groups. HFD males and females consumed a 
similar number of calories from HFD during 1-hour food exposure (Fig. 15A, effect of sex, 
p>0.05; main effect of number of exposures, p<0.0001; interaction, p<0.05; two-way ANOVA). 
HFD males consumed more hopper chow (Fig. 15B, main effect of sex, p<0.01; main effect of 
number of exposures, p<0.0001; interaction, p<0.0001; two-way ANOVA), and more total daily 
calories (Fig. 15C, main effect of sex, p<0.01; main effect of number of exposures, p<0.0001; 
interaction, p<0.0001; two-way ANOVA) than HFD females. Nonetheless, males and females 
consumed a similar proportion of their daily calories from HFD on intermittent access days (Fig. 
15D, effect of sex, p>0.05; main effect of number of exposures, p<0.0001; interaction, p>0.05; 
two-way ANOVA). Thus, the intensity of binge eating is similar between sexes. 
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Figure 12. 6wMWF intermittent HFD access induces binge-like feeding in female rats. 
A. Caloric intake from food provided in-cage for 1h.  B. 24h intake of chow provided ad libitum 
via a food hopper. C. Daily total calorie intake was calculated as a sum of 24h-intake of chow 
provided ad libitum and 1h-intake of chow, HFD or WD.   D. Percentage of calories consumed 
during the 1h access to chow or HFD with respect to total daily caloric intake. Chow (n=7), open 
white triangles; HFD (n=6) closed red triangles. *p<0.05, **p<0.01, ***p>0.001, ****p<0.0001. 
Black arrowheads represent 1h in-cage food exposures. 
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Figure 13. 1h access to HFD does not alter total daily food intake in female rats 
A. For the HFD group, total daily caloric intake on binge day consisted of calories from hopper 
chow over 24h plus calories from in-cage HFD during the 1-hour access. Total caloric intake on 
the subsequent day was only calories from hopper chow. B. 24-h chow intake from the hopper on 
binge day versus the subsequent day. Chow (n=7), open white triangles; HFD (n=6) closed red 
triangles.  Binge day, solid line; subsequent day, dashed line. 
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Figure 14. 6wMWF access to HFD does not alter body weight gain in female rats 
A. Initial body weights for 6wMWF chow (n=7) and HFD (n=6) groups. B. Body weight gain 
was calculated as initial weight subtracted from final weight before sacrifice. 
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Figure 15. 6wMWF exposure to HFD induces a similar magnitude of binge eating in male 
and female rats 
A. Caloric intake from food provided in-cage for 1h.  B. 24h intake of chow provided ad libitum 
via a food hopper. C. Daily total calorie intake was calculated as a sum of 24h-intake of chow 
provided ad libitum and 1h-intake of chow, HFD or WD. D. Percentage of calories consumed 
during the 1h access to chow or HFD with respect to total daily caloric intake. Male (n=7), 
closed blue circles; Female (n=6) closed red triangles. *p<0.05, **p<0.01, ***p>0.001, 
****p<0.0001. Black arrowheads represent 1h in-cage food exposures. 
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3.2 Electrophysiological properties of lateral hypothalamic neurons in binge eating 
animal model 
 Using the animal model established above, we investigated the electrophysiological 
changes in orexin and MCH neurons associated with binge eating. 
3.2.1 Identification of orexin neurons 
 Orexin neurons are localized in the lateral hypothalamus and perifornical area, and 
characterized by their relatively large size compared to other neurons in the same area. Our lab 
has previously established a reliable method of identifying orexin neurons in young rats aged 3 
to 4 weeks based on certain electrophysiological properties and post-hoc immunohistochemistry  
(Belanger-Willoughby et al., 2016; Linehan et al., 2015; Parsons et al., 2012). Specifically, 
Orexin neurons could be identified by H-currents upon application of hyperpolarizing currents, 
rebound depolarization often capped by action potentials after removal of hyperpolarizing 
currents, as well as spontaneous activity in the absence of current injection. The present study 
found the same electrophysiological characteristics in orexin neurons from rats six and eleven 
weeks old (Fig. 16A). A majority of cells that displayed these characteristics were confirmed to 
be immunopositive for orexin A (120 of 145 cells) and were included in the analysis (Fig. 16B). 
The remaining 25 neurons (17.2%) were not successfully filled with biocytin, however the latter 
subgroup was also included in the analysis because they displayed electrophysiological 
responses to hyperpolarizing and depolarizing currents typical of orexin neurons. 
3.2.2 Properties of Orexin neurons in 1wDaily access group 
 Using a series of positive and negative step current injections in current clamp mode, we 
analyzed electrophysiological parameters in order to detect any differences between the three 
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diet groups under the daily intermittent access paradigm. Resting membrane potential did not 
differ between the control (-47.2±4.1mV, n=17 cells from 7 rats), HFD (-46.6±3.1mV, n=24 
cells from 8 rats), or WD (-45.9±3.9mV, n=10 cells from 4 rats) groups (Fig. 16C, p>0.05, one-
way ANOVA). Furthermore, no significant differences were found in spontaneous action 
potential frequency between the three groups (Fig. 16D, p>0.05, one-way ANOVA). In response 
to positive current injections, there was no overall difference in latency to the first spike between 
the groups (Fig. 16E, effect of diet, p>0.05; main effect of current injection, p<0.0001; 
interaction, p<0.05; two-way ANOVA). However, multiple comparisons revealed that the 50pA 
current injection was shorter in orexin neurons from HFD group compared to control group 
(p<0.05). There was no change in the threshold (Fig. 16F, p>0.05, one-way ANOVA) or the 
number of elicited action potentials (Fig. 16G, effect of diet, p>0.05; main effect of current 
injection; interaction, p>0.05; two-way ANOVA).  Together, these results suggest that one week 
of intermittent HFD access does not affect basal excitability of orexin neurons, but may increase 
their sensitivity to depolarizing stimuli. 
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Figure 16. 1wDaily intermittent access to HFD, but not WD, alters excitability of orexin 
neurons 
A. Above: Representative traces for orexin neurons following application of current steps. Below: 
Diagram illustrating current injection protocol for traces above. B. Fluorescent 
immunohistochemistry showing neuron labelled with biocytin, orexin A peptide and overlay. C. 
Resting membrane potential averaged from nine traces before current injection. D. Spontaneous 
action potential frequency in absence of current injection. E. Latency to first spike following 
injection of positive current. F. Average threshold to first spike obtained from positive current 
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injection. G. Elicited action potential frequency following application of positive current. 
*p<0.05. 
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3.2.3 Properties of orexin neurons in 2wMWF access group 
 In orexin neurons from the rat groups given intermittent access to 1h HFD or chow three 
times a week for two weeks, resting membrane potential did not differ significantly between the 
control and HFD group (-46.0±3.7mV, n=19 cells from 4 rats and -47.6±3.2mV, n=23 cells from 
4 rats, respectively, Fig. 17B, p>0.05, Student’s t-test), and spontaneous action potential 
frequency was not different between the two groups (Fig. 17C, p>0.05, Student’s t-test). 
Moreover, latency to first spike (Fig. 17D, effect of diet, p>0.05; main effect of current injection, 
p<0.0001; interaction, p>0.05; two-way ANOVA), firing threshold (Fig. 17E, p>0.05, Student’s 
t-test) and action potential frequency (Fig. 17F, effect of diet, p>0.05; main effect of current 
injection, p<0.0001; interaction, p>0.05; two-way ANOVA) during positive current injections 
did not differ significantly between the groups. 
 Additionally, a current ramp was used to further assess differences in the excitability of 
orexin neurons. There was a significant difference in rheobase between control and HFD groups 
(Fig. 18B, p<0.05, Student’s t-test), but there was no difference in action potential frequency 
during the ramps (Figure 18C, p>0.05, Student’s t-test). 
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Figure 17. 2wMWF intermittent access to HFD does not alter orexin neuron excitability 
A. Above: Representative traces for orexin neurons following application of current steps. Below: 
Diagram illustrating current injection protocol for traces above. B. Resting membrane potential 
averaged from nine traces before current injection. C. Spontaneous action potential frequency in 
absence of current injection. D. Latency to first spike following injection of positive current. E. 
Average threshold to first spike obtained from positive current injection. F. Elicited action 
potential frequency following application of positive current. 
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Figure 18. More positive current is necessary to invoke the first action potential in orexin 
neurons following 2wMWF intermittent access to HFD 
A. Above: Representative trace for chow orexin neuron following application of current ramp. 
Middle: Representative trace for HFD orexin neuron following application of current ramp. 
Below: Diagram illustrating current ramp protocol for orexin neurons. B. Rheobase for orexin 
neurons in 2wMWF chow and HFD groups. Rheobase was defined as the minimum current 
necessary to elicit an action potential. C. Action potential frequency of orexin neurons following 
application of current ramp. *p<0.05.  
59 
  
3.2.4 Properties of orexin neurons in male and female 6wMWF access groups 
In male rats that underwent 6 weeks of three weekly intermittent access to HFD, the 
resting membrane potential of orexin neurons was significantly hyperpolarized compared to the 
control group (HFD: -50.2 ±1.1, n=6 cells from 4 rats, control: -46.8±0.6, n=13cells from 4 rats, 
Fig. 19B, p<0.01, Student’s t-test) although no difference in spontaneous action potential 
frequency was found (Fig. 19C, p>0.05, Student’s t-test). There was no overall difference in 
latency to 1st spike in orexin neurons between control and HFD males (Fig. 19D, effect of diet, 
p>0.05; main effect of current injection, p<0.0001; interaction, p>0.05; two-way ANOVA). 
Multiple comparisons revealed that latency to first spike was longer in orexin neurons from the 
HFD group at 50pA current injection compared to control condition (p<0.01). There were no 
significant differences in the threshold between the two groups (Fig. 19E, p>0.05, Student’s t-
test) or frequency of action potentials elicited by positive current injections (Fig. 19F, effect of 
diet, p>0.05; main effect of current injection, p<0.0001; no interaction, p>0.05; two-way 
ANOVA). 
In females, there was also a significant difference in the resting membrane potential of 
orexin neurons between control (-46.51 ± 0.6570, n=19 cells from 4 rats) and HFD (-48.32 ± 
0.6159, n=14 cells from 3 rats, Fig. 20B, p<0.05, Student’s t-test). However, there were no 
differences in spontaneous action potential frequency (Fig. 20C, p>0.05, Student’s t-test), latency 
to first spike (Fig. 20D, effect of diet, p>0.05; main effect of current injection, p<0.0001; 
interaction, p>0.05; two-way ANOVA), threshold (Fig. 20E, p>0.05, Student’s t-test), or elicited 
action potential frequency (Fig. 20F, effect of diet, p>0.05; main effect of current injection, 
p<0.0001; interaction, p>0.05; two-way ANOVA). 
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We also analyzed the membrane resistance of orexin neurons in males and females in the 
6wMWF groups. In orexin neurons from male rats, there was a significant negative correlation 
between resting membrane potential and membrane resistance, such that the more hyperpolarized 
the cells were, the higher the membrane resistance (Fig. 21A, R
2
=0.2091, p<0.05, linear 
regression). However, there was no significant difference in membrane resistance between cells 
from chow and HFD males (p>0.05, Student’s t-test). In orexin neurons from female rats, there 
was no correlation between resting membrane potential and membrane resistance (Fig. 21B, 
R
2
=0.0012, p>0.05, linear regression). Nonetheless, there was a difference in membrane 
resistance between cells from chow and HFD females (p<0.01, Student’s t-test). This may 
indicate an inherent difference between male and female orexin neurons, where channels closing 
hyperpolarize male orexin neurons regardless of diet, and intermittent HFD opens channels that 
hyperpolarize female orexin neurons. 
Overall, these results suggest that long-term, but not short-term binge-like feeding on 
HFD decreases orexin neuron excitability by hyperpolarizing them, and this may affect males 
and females via distinct mechanisms.  
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Figure 19. 6wMWF intermittent access to HFD hyperpolarizes and decreases excitability of 
orexin neurons in male rats 
A. Above: Representative traces for orexin neurons following application of current steps. Below: 
Diagram illustrating current injection protocol for traces above. B. Resting membrane potential 
averaged from nine traces before current injection. C. Spontaneous action potential frequency in 
absence of current injection. D. Latency to first spike following injection of positive current. E. 
Average threshold to first spike obtained from positive current injection. F. Elicited action 
potential frequency following application of positive current. *p<0.05. 
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Figure 20. 6wMWF intermittent HFD access hyperpolarizes orexin neurons in female rats 
A. Above: Representative traces for orexin neurons following application of current steps. Below: 
Diagram illustrating current injection protocol for traces above. B. Resting membrane potential 
averaged from nine traces before current injection. C. Spontaneous action potential frequency in 
absence of current injection. D. Latency to first spike following injection of positive current. E. 
Average threshold to first spike obtained from positive current injection. F. Elicited action 
potential frequency following application of positive current. *p<0.05. 
 
63 
  
 
Figure 21. The correlation between resting membrane potential and membrane resistance 
by diet condition differs between sexes in 6wMWF groups 
A. Scatterplot illustrating the negative correlation between resting membrane potential and 
membrane resistance in orexin neurons from male rats. B. Scatterplot illustrating that there is no 
correlation between resting membrane potential and membrane resistance in orexin neurons from 
female rats. 
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3.2.5 Properties of orexin neurons in adolescent versus adult male controls 
 It is unknown whether the electrophysiological properties of orexin neurons undergo 
developmental changes between adolescence and adulthood. As such, it is possible that 
developmental changes may be interacting with the diet manipulation to affect orexin neurons. 
Therefore, we decided to compare the parameters of orexin neurons between control males in 
1wDaily, 2wMWF and 6wMWF conditions that are four, six and eleven weeks of age, 
respectively. There was no significant difference in resting membrane potential (Fig. 21A, 
p<0.05, Student’s t-test) or spontaneous action potential frequency (Fig. 21B, p<0.05, Student’s 
t-test). There were no overall differences between the groups in latency to 1st spike (Fig. 21C, 
effect of age, p>0.05; main effect of current injection, p<0.0001; interaction, p>0.05; two-way 
ANOVA,) although multiple comparisons showed the latency to first spike was longer in 
1wDaily compared to 2wMWF controls at 50pA current injection (p>0.05). There were no 
significant differences in threshold (Fig. 21D, p<0.05, Student’s t-test) and elicited action 
potential frequency (Fig. 21E, effect of age, p<0.05; main effect of current injection, p<0.0001; 
interaction, p>0.05; two-way ANOVA) were not significantly different between the three groups. 
This demonstrates that there may be developmental changes in orexin neurons’ 
electrophysiology between these ages.  
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Figure 22. Orexin neuron activity may undergo developmental changes in rats from 4 to 11 
weeks of age in male rats 
A. Resting membrane potential averaged from nine traces before current injection. B. 
Spontaneous action potential frequency in absence of current injection. C. Latency to first spike 
following injection of positive current. D. Average threshold to first spike obtained from positive 
current injection. E. Elicited action potential frequency following application of positive current. 
*p<0.05. 
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3.2.6 Identification of MCH Neurons 
Since we found a change in the resting membrane potential of orexin neurons following 
6wMWF feeding, we chose to investigate MCH neurons since they are located in similar regions 
and also associated with binge eating and addictive behaviors (Haemmerle et al., 2015; Karlsson 
et al., 2012; Smith et al., 2005). Morphologically, they are similar to orexin neurons in size, in 
that they are typically larger than other cell types located in the same areas. Our lab has shown 
previously that MCH neurons display unique electrophysiological responses to a series of 
hyperpolarizing and depolarizing current step pulses that are distinct to those seen in orexin 
neurons in animals from 3 to 4 weeks old (Alberto et al., 2011; Belanger-Willoughby et al., 
2016). In the present study, we found the same characteristics in older animals, including a lack 
of Ih upon hyperpolarizing currents, accommodation of action potential frequency in response to 
depolarizing currents, and no spontaneous activity at baseline (Fig. 22A). Out of 49 cells that 
showed these characteristics, 43 cells were confirmed to be immunopositive for MCH peptide 
(87.8% success, Fig. 22B). The other 6 cells were not successfully filled with biocytin, but were 
included in the analysis based on their electrophysiological responses to hyperpolarizing and 
depolarizing currents, which were typical of MCH neurons. 
3.2.7 MCH neuron properties in six-week males and females 
 In MCH neurons from male 6wMWF groups, the resting membrane potential was not 
significantly different between control and HFD (-59.5±4.0mV, n=17 cells from 4 rats, and -
57.1±4.9mV, n=10 cells from 3 rats, respectively, Fig. 22C, p>0.05, Student’s t-test). Likewise, 
the latency to first spike (Fig. 22D, effect of diet, p>0.05; main effect of current injection, 
p<0.0001; interaction, p>0.05; two-way ANOVA), action potential threshold (Fig. 22E, p>0.05, 
Student’s t-test) and the frequency of elicited action potentials also revealed no significant 
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differences (Fig. 22F, effect of diet, p>0.05; main effect of current injection, p<0.0001; 
interaction, p>0.05; two-way ANOVA). A current ramp from 0pA to 200pA revealed no 
significant differences in rheobase (Fig. 23B, p>0.05, Student’s t-test) or action potential 
frequency (Fig. 23C, p>0.05, Student’s t-test), between groups. 
 Similarly, in MCH neurons from the female 6wMWF group, there was no significant 
difference in the resting membrane potential of MCH neurons between control (-57.5±2.5mV, 
n=10 cells from 3 rats) and HFD (-59.5±1.6mV, n=11 cells from 3 rats, Fig. 24B p>0.05, 
Student’s t-test). Likewise, there was no difference between the two groups in the latency to first 
spike (Fig. 24C, effect of diet, p>0.05; main effect of current injection, p<0.0001; interaction, 
p>0.05; two-way ANOVA), the threshold to fire (Fig, 24D, p>0.05, Student’s t-test) or 
frequency of elicited action potentials (Fig. 24E, effect of diet, p>0.05; main effect of current 
injection, p<0.0001; interaction, p>0.05; two-way ANOVA). A current ramp from 0 pA to 200 
pA revealed no significant differences between rheobase (Fig. 25B, p>0.05, Student’s t-test) or 
action potential frequency (Fig, 25C, p>0.05, Student’s t-test). 
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Figure 23. 6wMWF intermittent access to HFD has no apparent effect on MCH neuron 
excitability in male rats 
A. Above: Representative traces for MCH neurons following application of current steps. Below: 
Diagram illustrating current injection protocol for traces above. B. Fluorescent 
immunohistochemistry showing neuron labelled with biocytin, MCH peptide and overlay. C. 
Resting membrane potential averaged from nine traces before current injection. D. Latency to 
first spike following injection of positive current. E. Average threshold to first spike obtained 
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from positive current injection. F. Elicited action potential frequency following application of 
positive current. Chow (n=19), HFD (n=10). 
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Figure 24. Current ramps do not reveal any effect of 6wMWF intermittent access to HFD 
on MCH neuron excitability in male rats 
A. Above: Representative trace for male chow MCH neuron following application of current 
ramp. Middle: Representative trace for male HFD MCH neuron following application of current 
ramp. Below: Diagram illustrating current ramp protocol for MCH neurons, showing a gradual 
current injection from 0pA to 200pA. B. Rheobase for male MCH neurons in 6wMWF chow and 
HFD groups. C. Action potential frequency of MCH neurons following application of current 
ramp.  
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Figure 25. 6wMWF intermittent access to HFD has no apparent effect on MCH neuron 
excitability in female rats 
A. Above: Representative traces for MCH neurons following application of current steps. Below: 
Diagram illustrating current injection protocol for traces above. B. Resting membrane potential 
averaged from nine traces before current injection. C. Latency to first spike following injection 
of positive current. D. Average threshold to first spike obtained from positive current injection. 
E. Elicited action potential frequency following application of positive current. Chow (n=10), 
HFD (n=12). 
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Figure 26. Current ramps do not reveal any effect of 6wMWF intermittent access to HFD 
on MCH neuron excitability in female rats 
A. Above: Representative trace for female chow MCH neuron following application of current 
ramp. Middle: Representative trace for female HFD MCH neuron following application of 
current ramp. Below: Diagram illustrating current ramp protocol for MCH neurons. B. Rheobase 
for female MCH neurons in 6wMWF chow and HFD groups. C. Action potential frequency of 
MCH neurons following application of current ramp. 
 
  
73 
  
Chapter 4 - Discussion 
 The current thesis had two main goals. The first was to characterize how intermittent 
palatable diet access affected the feeding behavior of rats. We found that two palatable diets, one 
high in fat and sugar (WD) and one high in fat (HFD), produced different intensities of binge-
like behavior, and that three intermittent HFD access paradigms with different intervals and 
number of access produced a similar degree of binge-like behavior. Furthermore, there were no 
significant differences in binge-like behavior between any HFD rats, indicating similar binge 
behavior between adolescent and adult, and male and female rats. The second goal was to 
uncover any potential effects that these feeding paradigms had on orexigenic neurons of the 
lateral hypothalamus. Short-term palatable diet access (6 intermittent episodes), either daily or 
three times per week appeared to have no effect on the excitability of orexin neurons. 
Conversely, long-term intermittent HFD access (total of 18 episodes, three times a week) 
hyperpolarized orexin neurons, but not MCH neurons. 
4.1 Induction of binge-like feeding following intermittent access 
 The definition of binge eating in animal models is poorly defined and often varies 
between studies (Avena et al., 2008 chapter; Corwin et al., 2008). In the current study, food 
intake during a 1h exposure was significantly higher in HFD and WD rats compared to chow 
controls, and accounted for a significant proportion of the animals’ total daily caloric intake. 
Similar results have been found for other high-fat food exposure paradigms, in which animals 
consumed approximately 50% of their daily calories in 1h (Wojnicki et al., 2006) or 2h (Corwin 
et al., 1998; Dimitriou et al., 2000). This can be considered binge-like feeding (Babbs et al., 
2012; Corwin, 2004; Corwin et al., 1998), as it covers the DSM-5's criterion of eating a much 
larger amount of food in a shorter period of time than would be expected (American Psychiatric 
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Association, 2013). This model of intermittent exposure to palatable diets has the benefit of 
being more clinically relevant to cases of eating disorders that feature normal eating habits and 
restricted intake of palatable foods, followed by binges on palatable foods when they are 
consumed, compared with studies involving stress or total food restriction to induce binge-like 
feeding. 
4.2 1wDaily intermittent access 
 All three groups of rats, chow control, HFD and WD exposed rats, consumed similar 
amounts of total daily calories, including ad libitum chow and food consumed during 1h food 
exposure. This is in agreement with other studies of daily binge-like feeding showing that chow 
control groups and palatable diet access groups consume a similar amount of total calories 
(Avena et al., 2008; Corwin et al., 1998). The HFD group consumed less calories from chow 
compared to both chow control and WD groups, which may be a compensatory mechanism. 
Animals sometimes decrease their chow intake in response to binge-like feeding to maintain a 
homeostatic baseline of caloric intake (Avena et al., 2008; Corwin et al., 1998; Vickers et al., 
2015). That the HFD but not WD group reduced chow intake is likely due to the calories 
consumed from the diets; HFD rats consumed more calories during the intermittent feeding than 
WD group, so they decreased their baseline chow intake to accommodate for the extra calories. 
This is dissimilar to previous research indicating that access to a sweet-fat diet results in a 
decrease in chow intake (Berner et al., 2008). Since rats consumed more calories from the HFD 
than the WD, this suggests that HFD produced greater binge-like feeding. It is possible that 
palatability or physical factors of the foods, including the texture or taste, or the higher caloric 
density of HFD compared to chow (5.24kcal/g for HFD compared to 3.16kcal/g for chow, and 
4.49kcal/g for WD) may have contributed to this observed difference, as other studies that used 
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high fat and sweet-fat diets have not reported a difference in binge-like feeding between these 
styles of diets (Berner et al., 2008; Bocarsly et al., 2011). However, it is possible that high fat 
versus high sugar and fat diets have different mechanisms governing their ingestion. For 
example, Berner and colleagues have found that administration of baclofen, a GABAB receptor 
agonist, preferentially decreases binge-like intake of a fatty food, has no effect on sucrose 
bingeing, and increases intake of a sugary, fatty diet (Berner et al., 2008). 
4.3 Three different intermittent access models produce similar binge-like behavior 
 Previous studies have demonstrated that the more limited the access is to a palatable fatty 
food, the more it is consumed when it becomes available. Corwin et al. (1998) compared adult 
male rats on their consumption of Crisco when it was available, daily for 2h, three times per 
week for 2h or ad libitum, and found that the highest rates of consumption occurred when it was 
available only three times a week. In a paradigm comparing a chow-only group to three 
schedules of shortening access, including 2h daily, 2h MWF or ad libitum, total calories 
consumed during the 2h exposures increased above control and ad libitum by the second week. 
Additionally, during the exposure period calorie consumption in the 2h MWF group surpassed 
that of the 2h daily group by the end of the second week (Dimitriou et al., 2000). These findings 
are in contrast to our own, where both the 1wDaily and 2wMWF groups consumed a similar 
proportion of their daily calories from HFD. Because this was the case, we wondered whether 
increasing the number of intermittent exposures would result in an increase in the proportion of 
HFD consumed. However, extending the intermittent exposures at a rate of 3 times a week for 6 
weeks did not result in further increase in the percent of daily caloric intake from HFD.  
 Feeding behaviors appear to vary between other studies of binge eating as well. Davis 
and colleagues (2007) compared the daily caloric intake of a chow control group of rats with 
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groups given 2h access to Crisco or another HFD either daily or every 3 days, in addition to ad 
libitum chow and water. They found that the group given daily access consumed a similar 
number of calories as the chow group, whereas the group receiving access every 3 days 
consumed significantly more calories on the exposure day, and significantly less calories on the 
day following exposure to Crisco or HFD. Berner and colleagues (2008) compared a chow 
control group with rats given either ad libitum or 2h daily or MWF access to a sweet-fatty diet, 
and found their intake escalated over repeated exposures before plateauing in caloric intake by 
approximately the fourth exposure. However, in our study the MWF group consumed a similar 
number of calories on the subsequent days as the binge day. This illustrates that food intake 
between binge studies is variable and dependent upon specific methodology.    
Specific variables may be able to account for these observed differences between studies, 
including our own. The intermittent diets used for our experiments were not identical to those 
used in others. For example, we used rodent-formulated sweet-fat and high-fat diets whereas in 
the experiments briefly discussed above, Corwin (1998) and Davis (2007) and colleagues used 
Crisco. In the current study, we used a 1h access to palatable diet paradigm, however Davis 
(2007) and Dimitriou (2000) used a 2h access paradigm. Finally, the time of day may have 
played a role. In our experiments, palatable diet access was given six hours before onset of the 
dark phase. In the experiment discussed above, Berner and colleagues (2008) provided their 
sweet-fat diet during the dark phase. Taken together, these methodological differences may 
account for these variations between the current study and the results cited from the literature. 
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4.4 Comparison of adolescent and adult male feeding behavior 
 Specific diets and feeding paradigms vary greatly between studies, though many studies 
consistently make use of older animals to study binge-like feeding. Our feeding paradigms 
started when rats were juvenile, between 21 to 28 days old and weighed between 40g to 100g. 
However, much of the literature referenced cite older ages, including 60 days (Corwin et al, 
1998, Dimitriou et al., 2000), 90 days (Boggiano et al., 2007), or weights from 200g to 250g at 
the start of their studies. Bekker and colleagues (2014) compared two rat strains, one prone to 
overeating and obesity and one as a lean control, and compared the feeding behavior of 
adolescents (35-40 day old) and adults (105-115 days old) within and between these two strains. 
In their feeding paradigm, rats were given access to vanilla Ensure, a sweet-fat liquid meal 
replacement. They found that both strains of adolescent rats increased their intake of Ensure 
more than the adult rats following repeated exposures. As for chow intake, adult rats of both 
strains decrease their chow intake to compensate for excess caloric intake from bingeing, 
whereas both groups of adolescent rats consume more chow weekly after repeated exposures to 
Ensure. Our results are mostly inconsistent with this finding. In none of our experiments did the 
WD or HFD binge eating groups increase 24h chow intake relative to their respective control 
groups. Neither the 2wMWF nor the 6wMWF male or female HFD rats consumed a different 
amount of total calories on the HFD exposure day compared to the day after. Differences in 
feeding behavior between different strains of rats, and age at the start of feeding manipulation 
may be able to account for these differences.  
4.5 Comparison of male and female binge-like behavior  
The human incidence of eating disorders is generally higher in females than males 
(Hudson et al., 2007; Kessler et al., 2013). Additionally, in a study comparing adult male and 
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female rats on MWF consumption of a sweet-fat diet, female rats were found be significantly 
more likely to be binge-eating prone compared to male rats (Klump et al., 2013). Another study 
classified Sprague-Dawley males as being resistant to binge eating, whereas Sprague-Dawley 
females were classified as being prone to binge eating (Hildebrandt et al., 2014). Therefore, we 
compared the effect of intermittent feeding paradigm on female and male rats using the 6wMWF 
feeding paradigm. However, we did not find any differences in the magnitude of binge-like 
feeding in the 6wMWF HFD female group compared to the male group. While the notion of 
binge-eating proneness versus resistance may represent useful phenotypic or genotypic 
distinction between animals, the number of animals used in our studies was too low to reliably 
distinguish between these feeding phenotypes. Our findings indicate that male and female rats 
engage in similar binge-eating behavior when exposed to our specific feeding paradigm.  
 While eating disorders are often diagnosed more in woman than in men, some studies 
suggest that there are more similarities than differences between the sexes in binge-eating 
behavior. Striegel-Moore and colleagues found that significantly more women than men met the 
most conservative criteria for binge-eating, although when partial diagnoses were included this 
only accounted for one more female case of binge-eating for every 50 women compared to every 
50 men (Striegel-Moore et al., 2009). Thus, it may be that men are underrepresented in the 
statistical analysis of binge eating. The current study may reflect this, as we found no sex 
differences in binge-like behavior or frequency between male and female rats. 
4.6 Intermittent feeding and body weight 
Because binge-eating is often a risk factor or comorbid condition with obesity, we 
examined the weight gain of rats that experienced intermittent HFD exposure-induced binge 
eating, and compared to that of animals that did not binge eat. There were no significant 
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differences between any of the control and HFD groups, which is in agreement with previous 
studies. A possible reason for this may be partly due to the macronutrient levels in the diets 
provided, as intermittent high fat or sweet diets alone do not promote weight gain (Avena et al., 
2008; Corwin et al., 1998; Dimitriou et al., 2000), although sweet-fat diets do (Berner et al., 
2008). Thus, it may be possible that the WD used during our 1wDaily paradigm, which is a 
sweet-fat diet, could have promoted weight gain if it were available for the same duration as our 
6wMWF paradigm. In many binge-eating models animals reduce their calorie intake following 
an intermittent feeding episode as we have seen in our study, which maintains calorie intake, and 
thus body weight, similar to that of controls. These animal models thus may resemble an aspect 
of certain forms of binge-eating seen in human populations where people restrict their food 
intake in between binges in order to maintain an ideal weight. 
4.7 Orexin neurons of young and adult rats exhibit similar electrophysiological 
properties 
 Our lab has repeatedly demonstrated that orexin neurons from young rodents (3 to 4 week 
old) can be identified by their unique responses to hyperpolarizing and depolarizing current 
injections (Belanger-Willoughby et al., 2016; Linehan et al., 2015; Parsons et al., 2012). The 
work in this thesis has demonstrated that the same electrophysiological characteristics are seen in 
orexin neurons from older animals (10 to 11 weeks old), further solidifying that these are reliable 
characteristics for identifying these unique neural populations in rats. 
 Furthermore, comparing the electrophysiological properties between four, six and eleven 
week old rats in the chow condition, we found that there were no significant differences in any of 
the parameters we measured, except for a difference in latency to first spike at the 50pA injection 
between four and six week old rats. This difference was not found between the four and eleven 
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week old rats, thus it may be possible that it reflects a transient developmental change. Future 
studies may be able to further examine other developmental changes that occur in orexin 
neurons, as these may be responsible for changes in locomotory or feeding behaviors that are 
necessary for physical or behavioral development. 
4.8 Long-term, but not short-term HFD intermittent access hyperpolarizes orexin 
neurons 
 Despite the fact that there were no observable differences in the binge-like behavior 
between the 1wDaily, 2- and 6wMWF groups in terms of  the proportion of total calories 
consumed from HFD, our results suggest that there is a time-dependent change in the excitability 
of orexin neurons. Specifically, there are no changes in the resting membrane potential or 
spontaneous action potential frequency of orexin neurons in the short-term access paradigm 
(1wDaily and 2wMWF), whereas orexin neurons are hyperpolarized following long-term 
intermittent access to HFD. This effect was seen in both the male and female 6-week MWF rats. 
This suggests that the changes in orexin neurons in response to intermittent HFD access only 
occur with long-term, repeated exposures. 
 These results may be in conflict with a number of other studies showing that orexin 
neuron activity is related to the consumption of palatable foods or appetitive substances. In fact, 
some have reported that binge-like consumption of either palatable foods or other salient 
reinforcers such as ethanol result in an increase in orexin activity or expression. Orexin mRNA 
expression was found to be increased 30, 60 and 90 minutes following a sucrose solution binge 
compared to controls that drank water (Furudono et al., 2006). Likewise, an increase in orexin 
and OX2 receptor mRNA in the paraventricular nucleus of the thalamus was found following 
ethanol consumption (Barson et al., 2015), and long-term fructose bingeing in food-deprived rats 
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resulted in an increase in orexin-A release and orexin activity as measured by co-localization of 
c-fos (Rorabaugh et al., 2014). 
 However, decreases in orexin expression have also been reported following consumption 
of sweet solutions and ethanol. Using drinking-in-the-dark procedures, an alternative method of 
inducing binge-like consumption, up to four exposures to sucrose or saccharin solutions, but not 
water, decreased orexin mRNA expression in the lateral hypothalamus (Alcaraz-Iborra et al., 
2014; Carvajal et al., 2015). Furthermore, short-term ethanol or sucrose bingeing also decreased 
the number of orexin-A labelled neurons in the lateral hypothalamus (Olney et al., 2015). 
However, of note, the authors of these studies suggest that the observed decrease in orexin 
expression may reflect a temporary, adaptive decrease in orexin production following increased 
activity that occurs post-ingestion of these substances. Whether this decrease in orexin 
expression is analogous to the hyperpolarization observed in the current study remains unknown. 
 It is apparent that short- and long-term bingeing paradigms may affect orexin neurons 
differently. For example, chronic ethanol consumption has been shown to decrease orexin 
mRNA expression (Morganstern et al., 2010), and chronic ad libitum HFD consumption reduces 
the number of orexin-A positive neurons in mice (Nobunaga et al., 2014). These observations 
may agree with the hyperpolarization of orexin neurons we observed in the long-term bingeing 
groups but not the short-term groups. Together, these studies may highlight the difference in how 
orexin neurons respond to salient, rewarding stimuli in short-term versus the long-term bingeing. 
4.9 No observable effect of intermittent HFD on MCH neurons 
 We found no observable effect of intermittent HFD on MCH neuron activity. Levels of 
MCH peptide have been shown to be unaffected by chronic HFD consumption (Nobunaga et al., 
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2014), but elevated levels are found in rats prone to overconsuming HFD (Morganstern et al, 
2010), and higher levels of blood triglycerides following a fatty meal are positively correlated 
with MCH peptide levels (Karatayev et al., 2009). Orexin and MCH neurons are known to be 
reciprocally connected (Guan et al., 2002), and to project to and from some of the same  brain 
regions including the nucleus accumbens (Haemmerle et al., 2015; Mukai et al., 2009) and 
arcuate nucleus (Della-Zuana et al., 2002; Yamanaka et al., 2000). It is possible that these 
intermittent feeding paradigms are affecting the activity of these other nuclei as well. If long-
term intermittent palatable food access is affecting orexin neurons, it is possible that MCH 
neurons are being modulated indirectly in some ways that are not evident in the parameters we 
examined. Nevertheless, the difference in the effects observed between orexin and MCH neurons 
despite their proximity towards one another, reciprocal connections and shared efferents 
highlights the complexity of neural networks governing food intake and motivated behaviors. 
4.10 Potential mechanisms of altered orexin activity 
 The mechanism underlying the hyperpolarization of orexin neurons observed in these 
experiments remains unknown. Some possibilities underlying this change include alterations in 
presynaptic excitatory or inhibitory transmission or postsynaptic changes including modulation 
of receptors, channels or ionic pumps. One speculation is that intermittent palatable food access 
promotes changes in the brain similar to those of drug abuse, hence the popularity of the term 
“food addiction.” Alterations in the dopaminergic system have been noted in drug addicted and 
obese individuals, as both conditions show a decrease in the function of dopamine D2 receptors 
(Noble, 2000; Stice et al., 2009), which has also been demonstrated in obesity-prone rats (Geiger 
et al., 2009). Furthermore, D2 receptor activation has been shown inhibit GABAergic 
transmission to orexin neurons (Linehan et al., 2015). It may be possible that the chronic 
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downregulation of D2 receptors that occurs in addictive states, obesity or binge-eating results in 
an  increase in GABA signaling to orexin neurons, possibly contributing to the hyperpolarization 
of orexin neurons. To test this possibility, future studies could measure dopamine-induced 
changes in inhibitory transmission onto orexin neurons under feeding conditions that induce 
binge eating. 
4.11 Physiological implications of decreased orexin activity 
 The administration of orexin (Choi et al., 2010) or orexin receptor antagonists (Cason & 
Aston-Jones, 2014; Choi et al., 2010; Piccoli et al., 2012) in control animals has been found to 
increase and decrease palatable food intake, respectively. However, orexin neurons mediate a 
number of other physiological behaviors, including mood, sleep-wake cycles, arousal and 
motivation. Thus, the decrease in orexin excitability seen in the HFD group may have more 
effects than on feeding behavior. It is possible that this group of rats may exhibit lower levels of 
arousal or locomotion, as can be observed with high doses of orexin receptor antagonists 
(Winrow et al., 2011). Orexin deficiency results in the sleep disorder narcolepsy (Chemelli et al., 
1999), so hyperpolarization of these cells may result in a hypersomnolent phenotype compared to 
controls. Those with binge-eating disorders have higher rates of mental illness, most notably 
depression, which results in lower levels of arousal, sleep problems and decreased motivation 
and sensations of pleasure (DSM-5, 2013; Hudson et al., 2007). It is possible that a decrease in 
orexin excitability in response to long-term binge eating may be at least partly responsible for 
these effects in humans suffering from binge-eating. 
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4.12 Limitations of the current study 
 The current study was conducted in order to assess the effects of intermittent palatable 
diet access on orexigenic neurons in the lateral hypothalamus. It was conducted in light of the 
deleterious effects that binge-eating has on physical and mental health in human populations. 
However, binge-eating has many different presentations in eating disorders, and a single animal 
model cannot represent the variability of the human conditions. As our paradigms did not make 
use of food restriction, stress, or other variables that are commonly present in various eating 
disorders, whether the effect on orexin or MCH neurons remains the same or not under different 
binge-inducing conditions is worth exploring in the future. This would help to better understand 
the complex interplay between binge eating and the activity of these neurons. 
 The current studies used a diet high in fat to promote binge-like food intake. Although the 
WD used in our 1wDaily paradigm represents a sweet-fat diet, our rats did not binge on this as 
much as the HFD. Regardless, other studies have made use of sweet or sweet-fat diets to induce 
bingeing behavior, and a sweet-fat diet may more accurately represent the kinds of foods that 
people commonly binge on. As mentioned previously, chronic HFD reduced the total number of 
orexin-A labelled neurons in mouse hypothalamus (Nobunaga et al., 2014) whereas chronic 
fructose bingeing increased orexin neuron activity (Rorabaugh et al., 2014). Studying the effect 
of binge-like feeding of a sweet-fat diet on orexin activity may bridge the gap between these 
studies. 
 The current study made extensive use of patch-clamp electrophysiology, using coronal 
brain slices. This procedure necessarily severs many of the connections between the neural 
populations of the brain, which may not be representative of the environment of these neural 
populations in vivo. However, this also suggests that the differences observed in orexin neurons 
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are intrinsic to these neurons, or due to changes in the local network or from intact synaptic 
connections from more distal brain regions. This is beneficial in order to identify the possible 
mechanisms by which these cellular changes are occurring. 
4.13 Conclusion 
 To the best of my knowledge, this thesis represents the first electrophysiological analyses 
of orexin and MCH neurons in an animal model of binge eating. The results suggest that long-
term repetition of intermittent access to high fat diet decreases the activity of orexin neurons, 
supporting past research describing a decrease in orexin peptide following long-term binge-like 
consumption of palatable foods or other reinforcers. Orexin neurons participate in many 
physiological behaviors, so a decrease in their excitability associated with binge-eating may also 
result in impairments in many functions outside of food intake. These impairments may coincide 
with the symptoms found in comorbid mental illnesses often associated with binge-eating 
disorder, including major depression and anxiety disorders. While the specific roles orexin and 
MCH play in the development or maintenance of binge eating remain unknown, future research 
on these neural populations may provide unique treatment options for binge eating. 
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